Stoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
Latest reported STOK revenue for 2025-12-31 was $184.4M. Net income was -$6.9M. STOK currently screens at market cap $1.88B.
Use this STOK page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the STOK quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the STOK SEC filings page. Lician reads the product cache first so this HTML stays unique to Stoke Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full STOK income, balance, and cash tables.